Asserter profile
The Bank of New York Mellon, as Collateral Agent
unclassified0 patents now1 ever0 cases filed during tenure2 connections
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Nthe_bank_of_new_york_mellon_as_collateral_agent["The Bank of New York Mellon, as Collate…"]
Nbausch_health_companies_bausch_health_ireland_bausch_health_["Bausch Health Companies Inc.; Bausch He…"]
Nbausch_health_ireland_valeant_sp_z_o_o_technolas_perfect_vis["Bausch Health Ireland Limited; Valeant…"]
Nbausch_health_companies_bausch_health_ireland_bausch_health_ -->|"2019 · Intellectual Property Security Agreement · 6815542"| Nthe_bank_of_new_york_mellon_as_collateral_agent
Nthe_bank_of_new_york_mellon_as_collateral_agent -->|"2025 · Release · 6815542"| Nbausch_health_ireland_valeant_sp_z_o_o_technolas_perfect_vis
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Nthe_bank_of_new_york_mellon_as_collateral_agent focal
class Nbausch_health_companies_bausch_health_ireland_bausch_health_ operating
class Nbausch_health_ireland_valeant_sp_z_o_o_technolas_perfect_vis operating
Patents previously held (1)
- US 68155422019-07-03 → 2025-04-08
Connected entities (2)
- Bausch Health Companies Inc.; Bausch Health Ireland Limited; Bausch Health, Canada Inc.; Technolas Perfect Vision GmbH; Valeant Pharma Poland; Valeant Pharmaceuticals Luxembourg S.à r.l.; Valeant Sp. z o.o.operating company1 patent
- Bausch Health Ireland Limited; Valeant Sp. z o.o.; Technolas Perfect Vision GmbH; Bausch Health Companies Inc.; Valeant Pharmaceuticals Luxembourg S.à r.l.; Bausch Health, Canada Inc.; Valeant Pharma Polandoperating company1 patent